0001144204-12-060778 Sample Contracts

LICENSE AND COLLABORATION AGREEMENT
License and Collaboration Agreement • November 9th, 2012 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

THIS LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into this 26th day of July 2006 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.

AutoNDA by SimpleDocs
AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT
License and Collaboration Agreement • November 9th, 2012 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

THIS AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (this “Amendment”), is entered into this 25th day of June 2007 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.

AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT
License and Collaboration Agreement • November 9th, 2012 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

THIS AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (this “Amendment”), is entered into this 2nd day of October 2009 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.

AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT
License and Collaboration Agreement • November 9th, 2012 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

THIS AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (this “Amendment”), is entered into this 8th day of July, 2009 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation, having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation, having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.

AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT
License and Collaboration Agreement • November 9th, 2012 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

THIS AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (this “Amendment”), is entered into this 21 day of December 2007 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.

AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT
License and Collaboration Agreement • November 9th, 2012 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

THIS AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (this “Amendment”), is entered into this 13th day of June 2007 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Horsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred herein individually as a “Party” or collectively, as the “Parties”.

Time is Money Join Law Insider Premium to draft better contracts faster.